Tenax Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1 | |||
EBITDA | -6,267 | -3,954 | -3,565 | -3,790 |
EBIT | -31,693 | 4,618 | -3,566 | -3,790 |
Net Income | -6,267 | -3,960 | -3,575 | -3,798 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,527 | -3,087 | -3,031 | -5,165 |
Cash | 94,851 | 98,310 | 9,384 | 12,549 |
Basic Shares | 298 | 21,161 | 1,958 | 1,219 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -7 | -113 | -108 | |
EBITDA | -8,226 | -10,930 | -32,364 | |
EBIT | -8,233 | -11,043 | -32,473 | |
Net Income | -17,602 | -7,710 | -11,047 | -32,474 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -14,811 | -5,903 | -12,015 | -10,861 |
Cash | 94,851 | 9,792 | 2,123 | 5,583 |
Basic Shares | 152,717 | 248 | 18 | 12 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.18 |
2024-09-30 | -$0.19 |
2024-06-30 | -$1.83 |
2024-03-31 | -$3.12 |
